Zobrazeno 1 - 1
of 1
pro vyhledávání: '"биллирубин"'
Originally D-penicillamine (D-PA) was used due to its potential benefits in the treatment of neonatal hyperbilirubinemia caused by hemolytic diseases in newborn infants or immaturity of the liver enzyme uridine 5-diphospho-glucuronosyltransferase (UD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c08666bab9089da3073de354a0a7f7a8
